[{"_id":"551f89af31cae9239deb1e10","会社名":"日本化薬(株)【4272】","証券コード":"4272","決算期":"2014年3月期","会計方式":"日本方式","決算発表日":"2014年5月8日","決算月数":"12か月","売上高":"160,080百万円","営業利益":"24,090百万円","経常利益":"26,496百万円","当期利益":"16,718百万円","EPS（一株当たり利益）":"92.25円","調整一株当たり利益":"92.25円","BPS（一株当たり純資産）":"918.35円","総資産":"247,592百万円","自己資本":"166,421百万円","資本金":"14,932百万円","有利子負債":"21,281百万円","自己資本比率":"67.2%","ROA（総資産利益率）":"7.08%","ROE（自己資本利益率）":"10.56%","総資産経常利益率":"11.22%","__v":0,"日付":"2015-04-04T06:50:23.215Z"},{"_id":"551f89af31cae9239deb1e11","会社名":"日本化薬(株)【4272】","証券コード":"4272","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年5月9日","決算月数":"10か月","売上高":"128,104百万円","営業利益":"17,066百万円","経常利益":"20,480百万円","当期利益":"12,342百万円","EPS（一株当たり利益）":"68.09円","調整一株当たり利益":"68.06円","BPS（一株当たり純資産）":"828.87円","総資産":"224,705百万円","自己資本":"150,238百万円","資本金":"14,932百万円","有利子負債":"16,308百万円","自己資本比率":"66.9%","ROA（総資産利益率）":"---","ROE（自己資本利益率）":"---","総資産経常利益率":"---","__v":0,"日付":"2015-04-04T06:50:23.215Z"},{"_id":"551f89af31cae9239deb1e12","会社名":"日本化薬(株)【4272】","証券コード":"4272","決算期":"2012年5月期","会計方式":"日本方式","決算発表日":"2012年6月28日","決算月数":"12か月","売上高":"147,109百万円","営業利益":"19,398百万円","経常利益":"19,916百万円","当期利益":"11,401百万円","EPS（一株当たり利益）":"62.89円","調整一株当たり利益":"62.86円","BPS（一株当たり純資産）":"745.30円","総資産":"204,674百万円","自己資本":"135,115百万円","資本金":"14,932百万円","有利子負債":"13,174百万円","自己資本比率":"66.0%","ROA（総資産利益率）":"5.56%","ROE（自己資本利益率）":"8.67%","総資産経常利益率":"9.72%","__v":0,"日付":"2015-04-04T06:50:23.215Z"},{"_id":"551f89af31cae9239deb1e13","会社名":"日本化薬(株)【4272】","証券コード":"4272","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年5月9日","決算月数":"10か月","売上高":"128,104百万円","営業利益":"17,066百万円","経常利益":"20,480百万円","当期利益":"12,342百万円","EPS（一株当たり利益）":"68.09円","調整一株当たり利益":"68.06円","BPS（一株当たり純資産）":"828.87円","総資産":"224,705百万円","自己資本":"150,238百万円","資本金":"14,932百万円","有利子負債":"16,308百万円","自己資本比率":"66.9%","ROA（総資産利益率）":"---","ROE（自己資本利益率）":"---","総資産経常利益率":"---","__v":0,"日付":"2015-04-04T06:50:23.217Z"}]